Last updated: October 8, 2023
Sponsor: Beijing Friendship Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia
Treatment
propofol and lidocaine
propofol and sufentanil
propofol and esketamine
Clinical Study ID
NCT05497492
lumen208
Ages 18-99 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
- undergoing diagnostic upper GI endoscopy under deep propofol sedation
- >18 year old
- meeting the classification I-III of American Society of Anesthesiologists (ASA)
- getting written informed consent
Exclusion
Exclusion Criteria:
- allergic reaction to planned medication
- gravis myasthenia
- history of psychological problems or psychiatric disease
- morbid obesity/obstructive sleep apnea
- acute upper respiratory infections
- asthma at acute stage
- history of unregulated or malignant hypertension
- history of significant ischemic heart disease or severe arrhythmia
- severe liver or kidney dysfunction or coagulation disorders
- acute upper GI haemorrhage with shock
- severe anaemia
- GI obstruction with gastric retention
- seizure disorders
- long-term history of sedative and analgesic drug use
- increased intracranial pressure.
Study Design
Total Participants: 400
Treatment Group(s): 4
Primary Treatment: propofol and lidocaine
Phase:
Study Start date:
November 05, 2022
Estimated Completion Date:
December 30, 2023
Study Description
Connect with a study center
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing 100050
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.